Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer

Clinical trial NCT00625664 · COMPLETED

Trial details

NCT number: NCT00625664
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms

Start date: 2008-02-01
Primary completion: 2011-02-01
Enrollment: 337

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.